XML 56 R45.htm IDEA: XBRL DOCUMENT v3.25.2
Note 12 - Related Party Transactions (Details Textual) - USD ($)
3 Months Ended 6 Months Ended
Apr. 06, 2021
Jul. 10, 2017
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Jan. 01, 2025
Dec. 31, 2024
Mar. 02, 2021
Mar. 01, 2021
Royalty Expense         $ 119,779   $ 94,950 $ 232,270 $ 210,642        
Professional Fees         900,591   753,796 $ 2,185,236 1,693,193        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)               0          
Consultant [Member]                          
Deferred Compensation Arrangement with Individual, Compensation Expense         50,000   50,000 $ 100,000 100,000        
Director Clinical Affair [Member]                          
Royalty Expense         119,000   95,000 232,000 211,000        
Professional Fees         39,000   78,000 39,000 78,000        
Director of Clinical Affairs [Member]                          
Accounts Payable and Accrued Liabilities, Current         $ 125,000     $ 125,000     $ 110,000    
Mr. Osser, Interim Chief Executive Officer [Member]                          
Royalty on Net Sales, Percentage                       2.50% 5.00%
Mr. Osser, Vice Chairman of Board [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) 2,000,000                        
Shares Issued and Owned by Investors, Balance, Shares (in shares)         2,717,765     2,717,765          
Shares To Be Issued at Employment Termination (in shares)         2,481,048     2,481,048          
Mr. Osser, Vice Chairman of Board [Member] | Share-Based Payment Arrangement, Option [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year) 5 years                        
Mr. Haverhals, Consultant and Director [Member]                          
Consulting Agreement, Annual Fee                   $ 350,000      
Payments for Consulting Services         $ 67,000 $ 150,000              
Consulting Agreement, Compensation Expense         $ 67,000     $ 216,000          
Shares To Be Issued after Employees Resignation (in shares)         912,736     912,736          
Mr. Haverhals, Consultant and Director [Member] | Forecast [Member]                          
Payments for Consulting Services     $ 67,000 $ 67,000                  
Manufacturing Agreement for Handpieces [Member]                          
Related Party Transaction, Purchases from Related Party         $ 285,000   423,000 $ 772,000 1,200,000        
Manufacturing Agreement for Handpieces [Member] | Related Party [Member] | Accounts Payable, Related Parties, Current [Member]                          
Accounts Payable and Accrued Liabilities         539,000     539,000     $ 663,000    
Employment Agreement [Member] | Mr. Osser, Vice Chairman of Board [Member]                          
Increase (Decrease) in Deferred Compensation   $ (100,000)                      
Employment Agreement, Base Compensation   200,000                      
Consulting Agreement [Member] | Mr. Osser, Vice Chairman of Board [Member]                          
Increase (Decrease) in Deferred Compensation   100,000                      
Employment Agreement, Base Compensation   $ 200,000                      
Purchased Medical Products [Member] | University Pain Medicine Center (STEMMEE) [Member]                          
Related Party Transaction, Amounts of Transaction         $ 15,000   $ 6,000 $ 21,000 $ 9,000